ecancer

OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

12 Oct 2020

ESMO 2020 melanoma roundup

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany

28 Sep 2020

Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

22 Sep 2020

OncoAlert and ecancer weekly roundup for August 30 - September 5 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

7 Sep 2020

OncoAlert and ecancer weekly roundup for August 1-8 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

17 Aug 2020

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V600–mutant melanoma

Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany

30 Jun 2020

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia

1 May 2020

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma

Prof Alain Algazi -University of California San Francisco, San Francisco, USA

30 Apr 2020

Where have we got to with cancer treatment?

Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

27 Jan 2020

The treatment landscape of occular melanoma

Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada

21 Oct 2019

CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

7 Oct 2019

IMspire170: New combination treatment for advanced melanoma

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

7 Oct 2019

More from ecancer